HRT Financial’s United Therapeutics UTHR Stock Holding History

HRT Financial’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$130M	Buy	+218,700	New	+$109M	0.32%	42

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

HRT Financial's UTHR Position: Q1 2026 in Review

HRT Financial increased its United Therapeutics (UTHR) stake by 5.4% in Q1 2026, buying an estimated $1.72M and bringing the position to 66,842 shares worth $39.6M. The position accounts for 0.1% of the portfolio, ranked #167.

HRT Financial first reported a position in UTHR in Q2 2019 and has held it in 19 quarters since. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

HRT Financial held 66,842 shares of United Therapeutics worth $39.6M as of Q1 2026.
HRT Financial bought 3,445 United Therapeutics shares in Q1 2026, an estimated $1.72M.
United Therapeutics made up 0.1% of HRT Financial's portfolio in Q1 2026, its #167 holding.
HRT Financial first reported a position in United Therapeutics in Q2 2019 and has held it in 19 quarters since.
850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.